Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arcus Biosciences Inc shares valued at $201,200 were purchased by KANEKO YASUNORI on Feb 27 ’25. At $10.06 per share, KANEKO YASUNORI acquired 20,000 shares. The insider’s holdings grew to 28,400 shares worth approximately $0.24 million following the completion of this transaction.
Also, ROSEN TERRY J purchased 19,800 shares, netting a total of over 201,465 in proceeds. Following the buying of shares at $10.18 each, the insider now holds 2,554,160 shares.
Before that, GILEAD SCIENCES, INC. had added 1,363,636 shares to its account. In a trade valued at $14,999,996, the 10% Owner bought Arcus Biosciences Inc shares for $11.00 each. Upon closing the transaction, the insider’s holdings increased to 1,363,636 shares, worth approximately $269.31 million.
As published in a research note from H.C. Wainwright on February 26, 2025, Arcus Biosciences Inc [RCUS] has been rated up from a Neutral to a Buy and the price target has been revised to $24 from $18. Analysts at H.C. Wainwright started covering the stock with ‘”a Neutral”‘ outlook in a report released in late October. As of October 08, 2024, Wells Fargo has initiated its “an Overweight” rating for RCUS. Earlier on November 18, 2022, BofA Securities initiated its rating. Their recommendation was “a Neutral” for RCUS stock.
Analyzing RCUS Stock Performance
During the last five days, there has been a surge of approximately 0.47%. Over the course of the year, Arcus Biosciences Inc shares have dropped approximately -42.44%. Shares of the company reached a 52-week high of $15.61 on 01/07/25 and a 52-week low of $6.50 on 04/07/25. A 50-day SMA is recorded $8.44, while a 200-day SMA reached $13.56.
Support And Resistance Levels for Arcus Biosciences Inc (RCUS)
According to the 24-hour chart, there is a support level at 8.31, which, if violated, would cause prices to drop to 8.05. In the upper region, resistance lies at 8.78. The next price resistance is at 9.00. RSI (Relative Strength Index) is 51.52 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.07, which suggests the price will decrease in the coming days. Percent R is at 34.06%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
